In a small clinical trial, scientists found that men with advanced prostate cancer and detection of androgen receptor splice variant-7 respond to chemotherapy just as well as men who lack the variant.
In a small clinical trial, scientists found that men with advanced prostate cancer and detection of androgen receptor splice variant-7 respond to chemotherapy just as well as men who lack the variant.